A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 9, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions

PharmacokineticsNeurology

Interventions

DRUG

AL001

Crystalized Lithium

DRUG

Lithium Carbonate Capsule

Lithium Carbonate

Trial Locations (1)

Massachusetts General Hospital, Boston